Increasing Survival of Patients with Severe SARS-CoV-2 Infection and/or Multi Organ Failure by up to 30% with ADVOS - ADVanced Organ Support

Project Information

ADVOS-COVID-19

Grant agreement ID: 961745

DOI 10.3030/961745

Project closed

EC signature date 27 July 2020

Start date 1 October 2020

End date 30 June 2023

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 1 381 605,00

EU contribution € 951 946,10

Coordinated by

ADVITOS GMBH
Germany

Intellectual Property Rights

Patent (1)

METHOD FOR EXTRACORPOREAL LUNG SUPPORT

Application/Publication number: 20 16078198
Date: 2016-11-18
Applicant(s): ADVITOS GMBH